HBIO
Harvard Bioscience Inc.

1,783
Mkt Cap
$30.83M
Volume
32,006.00
52W High
$9.46
52W Low
$2.81
PE Ratio
-0.54
HBIO Fundamentals
Price
$6.84
Prev Close
$6.90
Open
$6.90
50D MA
$5.68
Beta
1.93
Avg. Volume
69,094.37
EPS (Annual)
-$12.77
P/B
2.25
Rev/Employee
$255,309.73
$65.35
Loading...
Loading...
News
all
press releases
Harvard Bioscience (NASDAQ:HBIO) Director William Snider Purchases 8,475 Shares
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider purchased 8,475 shares of the stock in a transaction dated Tuesday, March 17th. The shares were bought at an average...
MarketBeat·2mo ago
News Placeholder
More News
News Placeholder
Harvard Bioscience (NASDAQ:HBIO) Director Stephen Denelsky Purchases 10,000 Shares
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director Stephen Denelsky acquired 10,000 shares of Harvard Bioscience stock in a transaction that occurred on Tuesday, March 17th. The shares...
MarketBeat·2mo ago
News Placeholder
Harvard Bioscience (NASDAQ:HBIO) Director William Snider Acquires 12,525 Shares
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider purchased 12,525 shares of the stock in a transaction dated Monday, March 16th. The stock was acquired at an average...
MarketBeat·2mo ago
News Placeholder
Insider Buying: Harvard Bioscience (NASDAQ:HBIO) Director Purchases 8,475 Shares of Stock
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider bought 8,475 shares of the stock in a transaction on Tuesday, March 17th. The stock was purchased at an average price...
MarketBeat·2mo ago
News Placeholder
John Duke Purchases 5,000 Shares of Harvard Bioscience (NASDAQ:HBIO) Stock
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) CEO John Duke bought 5,000 shares of the firm's stock in a transaction on Monday, March 16th. The shares were acquired at an average price of...
MarketBeat·2mo ago
<
...
1
>

Latest HBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.